Laura Lagares-Tena

Laura Lagares-Tena

UNVERIFIED PROFILE

Are you Laura Lagares-Tena?   Register this Author

Register author
Laura Lagares-Tena

Laura Lagares-Tena

Publications by authors named "Laura Lagares-Tena"

Are you Laura Lagares-Tena?   Register this Author

13Publications

310Reads

10Profile Views

High-resolution circuit for the diagnosis of faecal incontinence. Patient satisfaction.

Cir Esp 2017 May 8;95(5):276-282. Epub 2017 Jun 8.

Unidad de Cirugía Colorrectal, Servicio de Cirugía General, Hospital Universitari MútuaTerrassa. Universitat de Barcelona, Terrassa, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ciresp.2017.04.012DOI Listing
May 2017

The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy.

Front Oncol 2015 7;5:82. Epub 2015 Apr 7.

Sarcoma Research Group, Molecular Oncology Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat , Barcelona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2015.00082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387920PMC
April 2015

Prospects for MEK inhibitors for treating cancer.

Expert Opin Drug Saf 2014 Apr 6;13(4):483-95. Epub 2014 Mar 6.

The Royal Marsden Hospital , Fulham Road, London SW3 6JJ , UK +44 20 7811 8576 ; +44 20 7811 8103 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.2014.892578DOI Listing
April 2014

Targeted therapies in sarcomas: challenging the challenge.

Sarcoma 2012 3;2012:626094. Epub 2012 Jun 3.

Laboratori d'Oncología Molecular, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/626094DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372278PMC
August 2012

2-deoxyglucose induces Noxa-dependent apoptosis in alveolar rhabdomyosarcoma.

Cancer Res 2011 Nov 12;71(21):6796-806. Epub 2011 Sep 12.

Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-11-0759DOI Listing
November 2011

Caveolin-1 in sarcomas: friend or foe?

Oncotarget 2011 Apr;2(4):305-12

Sarcoma Research Group, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248165PMC
http://dx.doi.org/10.18632/oncotarget.255DOI Listing
April 2011

Caveolin-1 modulates the ability of Ewing's sarcoma to metastasize.

Mol Cancer Res 2010 Nov;8(11):1489-500

Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Duran i Reynals-3 Planta Gran via s/n Km. 2, 7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-10-0060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679656PMC
November 2010

The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.

Cancer Res 2009 Sep 8;69(18):7430-8. Epub 2009 Sep 8.

Group of Molecular Oncology, Biochemistry Research Center (CIBBIM-Nanomedicine) and Department of Pathology, Vall d'Hebron Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-0706DOI Listing
September 2009